Lin, JianMin <br/><br/>
The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity.  [electronic resource] 

 -  Cancer biology & therapy  Nov 2013 
 - 1032-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.4161/cbt.26106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Animals<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antibody-Dependent Cell Cytotoxicity<br/>Antineoplastic Agents--pharmacology<br/>Female<br/>Folate Receptor 1--metabolism<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Ovarian Neoplasms--drug therapy<br/>Receptors, IgG--metabolism